Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (521-530 of 546) with videos related to

Pageof 55
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Annals of Neurology|September 2, 2022
Microglial Activation and Connectivity in Alzheimer Disease and AgingBoris-Stephan Rauchmann, Matthias Brendel, Nicolai Franzmeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Disease Models & Mechanisms|November 19, 2021
A scalable, clinically severe pig model for Duchenne muscular dystrophyMichael Stirm, Lina Marie Fonteyne, Bachuki Shashikadze, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Acta Neuropathologica Communications|September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophagesLorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
JMIR Cancer|September 20, 2024
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective StudyAli Janbain, Andrea Farolfi, Armelle Guenegou-Arnoux, et al.
Pageof 55

Showing results (521-530 of 546) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Annals of Neurology|September 2, 2022
Microglial Activation and Connectivity in Alzheimer Disease and AgingBoris-Stephan Rauchmann, Matthias Brendel, Nicolai Franzmeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Disease Models & Mechanisms|November 19, 2021
A scalable, clinically severe pig model for Duchenne muscular dystrophyMichael Stirm, Lina Marie Fonteyne, Bachuki Shashikadze, et al.
Frontiers in Cardiovascular Medicine|April 25, 2020
Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and RationaleFlorian Lasch, Annika Karch, Armin Koch, et al.
Acta Neuropathologica Communications|September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophagesLorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
JMIR Cancer|September 20, 2024
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective StudyAli Janbain, Andrea Farolfi, Armelle Guenegou-Arnoux, et al.
Pageof 55